Wai Yuen Tong Medicine Holdings Limited Stock Hong Kong S.E.
Equities
0897
BMG9421Y2175
Pharmaceuticals
Sales 2022 | 1.39B 178M | Sales 2023 | 1.29B 165M | Capitalization | 434M 55.46M |
---|---|---|---|---|---|
Net income 2022 | -109M -13.94M | Net income 2023 | -20M -2.56M | EV / Sales 2022 | 1.1 x |
Net Debt 2022 | 1.17B 150M | Net Debt 2023 | 1.2B 153M | EV / Sales 2023 | 1.27 x |
P/E ratio 2022 |
-3.28
x | P/E ratio 2023 |
-21.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.98% |
Managers | Title | Age | Since |
---|---|---|---|
Ching Ho Tang
CEO | Chief Executive Officer | 62 | 01-08-27 |
Yuen Wo Tsang
CTO | Chief Tech/Sci/R&D Officer | - | 18-08-31 |
Seung Ming Wong
AUD | Comptroller/Controller/Auditor | 52 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ka Fai Li
BRD | Director/Board Member | 69 | 15-03-16 |
Ching Ho Tang
CEO | Chief Executive Officer | 62 | 01-08-27 |
Man Ho Siu
BRD | Director/Board Member | 50 | 01-07-31 |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |